Niederer Kraft Frey advised the arrangers on the financing of Bain and Cinven for the acquisition of Lonza’s Specialty Ingredients business and operations for an enterprise value of CHF 4.2 billion consisting of a combination of credit and sustainability-linked notes issuances. The transaction closed on 1 July 2021.

Lonza’s Specialty Ingredients business operates across 17 manufacturing sites globally and has approximately 2,800 permanent employees. The business is a leading provider of microbial control solutions for professional hygiene and personal care products. It also offers the custom development and manufacturing of specialty chemicals and composites to support the electronics, aerospace, food and agrochemical industries.

The NKF team was led by Finance/Capital Markets partner Marco Häusermann, working with junior associate Manuela Staudenmann (Finance/Capital Markets), counsels Christina Del Vecchio (Capital Markets) and Janine Reudt-Demont (Life Science) as well as partners Markus Kronauer (Tax) and Moritz Maurer (Corporate).